Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

@inproceedings{Chen2016ConsolidationCI,
  title={Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study},
  author={Xin-Ru Chen and Jian-zhong Liang and Shu-xiang Ma and Wen-Feng Fang and Ning-ning Zhou and Hai Liao and De-Lan Li and Li-kun Chen},
  booktitle={OncoTargets and therapy},
  year={2016}
}
BACKGROUND Concurrent chemoradiotherapy (CCRT) is the standard treatment for limited-stage small-cell lung cancer (LD-SCLC). However, the efficacy of consolidation chemotherapy (CCT) in LD-SCLC remains controversial despite several studies that were performed in the early years of CCT use. The aim of this study was to reevaluate the effectiveness and toxicities associated with CCT. METHODS This retrospective analysis evaluated 177 patients with stage IIIA and IIIB small-cell lung cancer (SCLC… CONTINUE READING